Search
forResearch 10 of 1000+
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- The Role of Janus Kinase Inhibitors in Dermatology
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
Learn 2 of 3
All learn results →Community
— no results
Try a deeper search in community →